Suchergebnisse - "Perruzza, Lisa"

PubPharm (33)

1

Broadly neutralizing antibodies against emerging delta-coronaviruses

enthalten in: bioRxiv.org | 2024

von Rexhepaj, M. | Park, Y. | Perruzza, L. | +17

2

Broadly neutralizing antibodies against emerging delta-coronaviruses

enthalten in: bioRxiv : the preprint server for biology | 2024

von Rexhepaj, M. | Park, Y. | Perruzza, L. | +17

3

The Shigella flexneri virulence factor apyrase is released inside eukaryotic cells to hijack host cell fate

enthalten in: Microbiology spectrum | 2023

von Perruzza, L. | Zagaglia, C. | Vitiello, L. | +8

4

ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSIS

enthalten in: Europäisches Patentamt | 2023

von GRASSI FABIO | PERRUZZA LISA

5

ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSIS

enthalten in: Europäisches Patentamt | 2023

von GRASSI FABIO | PERRUZZA LISA

6

Atp-hydrolyzing enzyme useful for treating dysbiosis

enthalten in: Europäisches Patentamt | 2022

von GRASSI FABIO | PERRUZZA LISA

7

Apyrase-mediated amplification of secretory IgA promotes intestinal homeostasis

enthalten in: Cell reports | 2022

von Perruzza, L. | Strati, F. | Raneri, M. | +14

8

Development of spirulina for the manufacture and oral delivery of protein therapeutics

enthalten in: Nature biotechnology | 2022

von Jester, B. | Zhao, H. | Gewe, M. | +42

ErratumIn: Nat Biotechnol. 2022 Apr 19;:. - PMID 35440781

9

Author Correction : Development of spirulina for the manufacture and oral delivery of protein therapeutics

enthalten in: Nature biotechnology | 2022

von Jester, B. | Zhao, H. | Gewe, M. | +42

ErratumFor: Nat Biotechnol. 2022 Jun;40(6):956-964. - PMID 35314813

10

ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSIS

enthalten in: Europäisches Patentamt | 2021

von GRASSI FABIO | PERRUZZA LISA